Compound Detail
CHEMBL4866309
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4866309 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KZGNMLQRICBTQX-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
273.7
MW (Da)
2.83
ALogP
4
HBA
1
HBD
67.9
PSA (Ų)
0.73
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.47 | 6.47 | 340.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 340.0 | nM | 6.47 | Inhibition of SARS-CoV-2 3CL protease using HiyteFluor-488ESATL-QSGLRKAK-(QXL)-N... | 34528437 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34528437 | 10.1021/acs.jmedchem.1c01214 | Unchecked | 1 |
| 34528437 | 10.1021/acs.jmedchem.1c01214 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine